An alternative go-to-market and pricing framework to enable value co-creation between pharmas and payers

Aware that the actual go-to-market and pricing framework is not anymore sustainable, OpusLine developed a new framework that delivers shared value among payers, patients and pharmaceutical companies. The modelization of this framework has been presented at ISPOR Europe 2019.   Background Over the past decade, pharmaceutical companies have faced challenges directly affecting their P&L: 69% Increase in trial duration in…...
#OpusLine Notre compte Twitter a évolué. Retrouvez nous dès maintenant à l'adresse suivante : @OpusLine

The increasing popularity of Real World Data with 186 studies presented at ASCO 2019

186 real-world data studies have been presented at ASCO 2019. These studies highlight the increasing awareness on the value of real world data and real world evidence. Among these studies, 113 studies were on the efficacy, the safety or the quality of life, 74 studies on the patient care and follow-up and 22 studies on medical practice.      …...

Results of the study “Industry of the future: challenges and perspectives for the health industry” led by OpusLine

  Innovative and positioned across the entire value chain, the drug, in vitro diagnostics and medical device industries are a strategic sector with a considerable economic weight in France. With a growing competitive intensity and a complexification of health product needs, they now need to rethink their positioning and their modes of operation. The integration of industry of the future…...

Health Data Hub: an ambitious French initiative for tomorrow’s health

A strategic tool to serve innovation and promote Artificial Intelligence in healthcare The French Health law project "Ma santé 2022" including the creation of the Health Data Hub and the “Espace Numérique de Santé” (ENS), e-health personal space, has been adopted  by the National Assembly on March 16th 2019. It should be under examination by the senate in May. At…...